A detailed history of Price T Rowe Associates Inc transactions in Inogen Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 25,586 shares of INGN stock, worth $289,889. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,586
Previous 23,868 7.2%
Holding current value
$289,889
Previous $193,000 8.29%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.3 - $8.95 $10,823 - $15,376
1,718 Added 7.2%
25,586 $209,000
Q1 2024

May 15, 2024

BUY
$5.26 - $10.15 $6,248 - $12,058
1,188 Added 5.24%
23,868 $193,000
Q4 2023

Feb 14, 2024

SELL
$4.21 - $6.32 $7,864 - $11,805
-1,868 Reduced 7.61%
22,680 $125,000
Q3 2023

Nov 14, 2023

BUY
$5.14 - $11.28 $44,425 - $97,493
8,643 Added 54.34%
24,548 $129,000
Q2 2023

Aug 14, 2023

BUY
$10.01 - $13.86 $1,751 - $2,425
175 Added 1.11%
15,905 $184,000
Q1 2023

May 15, 2023

BUY
$11.88 - $26.0 $4,062 - $8,892
342 Added 2.22%
15,730 $197,000
Q4 2022

Feb 14, 2023

BUY
$19.14 - $24.55 $81,345 - $104,337
4,250 Added 38.16%
15,388 $303,000
Q3 2022

Nov 14, 2022

BUY
$22.74 - $31.8 $31,017 - $43,375
1,364 Added 13.96%
11,138 $271,000
Q2 2022

Aug 15, 2022

BUY
$22.88 - $35.28 $20,706 - $31,928
905 Added 10.2%
9,774 $236,000
Q1 2022

May 16, 2022

BUY
$28.1 - $35.25 $20,428 - $25,626
727 Added 8.93%
8,869 $288,000
Q4 2021

Feb 14, 2022

BUY
$29.66 - $44.0 $31,291 - $46,420
1,055 Added 14.89%
8,142 $277,000
Q3 2021

Nov 15, 2021

BUY
$43.09 - $82.26 $5,601 - $10,693
130 Added 1.87%
7,087 $305,000
Q2 2021

Aug 16, 2021

SELL
$52.03 - $68.77 $86,473 - $114,295
-1,662 Reduced 19.28%
6,957 $453,000
Q1 2021

May 17, 2021

BUY
$43.96 - $55.99 $1,011 - $1,287
23 Added 0.27%
8,619 $453,000
Q4 2020

Feb 16, 2021

BUY
$27.19 - $44.68 $233,725 - $384,069
8,596 New
8,596 $384,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $259M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.